Search

Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.

Story1

OrbiMed-affiliated fund OPI VII reports 12.3% stake in Aspen Neuroscience

A Schedule 13D filed on 6 November 2026 shows OPI VII, a Delaware limited partnership managed by OrbiMed Advisors LLC, holds 3,589,132 shares of Aspen Neuroscience, Inc., equal to approximately 12.3% of the company's outstanding shares.

Story1

OrbiMed-affiliated fund OPI VII reports 12.3% stake in Aspen Neuroscience

Company or person29

Aspen Neuroscience, Inc.

Alto Neuroscience, Inc.

FIREFLY NEUROSCIENCE, INC.

ProMIS Neurosciences Inc.

JUPITER NEUROSCIENCES, INC.

Minerva Neurosciences, Inc.

NEUROCRINE BIOSCIENCES INC

Niagen Bioscience, Inc.

NeuroPace Inc

Dare Bioscience, Inc.

Skye Bioscience, Inc.

PURE BIOSCIENCE, INC.

Aura Biosciences, Inc.

ASSEMBLY BIOSCIENCES, INC.

Arcus Biosciences, Inc.

Anixa Biosciences Inc

Yarrow Bioscience, Inc.

ASPEN AEROGELS INC

Neurogene Inc.

Nexscient, Inc.

HARVARD BIOSCIENCE INC

SPRUCE BIOSCIENCES, INC.

Alamar Biosciences, Inc.

ARTELO BIOSCIENCES, INC.

Alzamend Neuro, Inc.

Ensysce Biosciences, Inc.

INTERPACE BIOSCIENCES, INC.

Arcadia Biosciences, Inc.

MBX Biosciences, Inc.